Parents of children with spinal muscular atrophy (SMA), a rare disease, welcomed the announcement by the Indian pharma ...

The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Natco Pharma started in Hyderabad with an investment of ₹3.3 million in 1981 and 20 employees working at a single unit. Today ...

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...

Affordable generic version of SMA drug Risdiplam soon available in India, offering hope to patients and activists.

The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify ...

Auditor/Auditors for Natco Pharma Ltd is/are B S R & Co. In the main management, V C Nannapaneni is chairman and Venkat Ramesh is the company secretary for Natco Pharma Ltd. Phones, computers ...

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With effect from the closure of business hours on 31st March, 2025, Mr.

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.<br/><br/> <table border=' ...